Correlation Between Viracta Therapeutics and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Viracta Therapeutics and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Vertex Pharmaceuticals.
Diversification Opportunities for Viracta Therapeutics and Vertex Pharmaceuticals
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Viracta and Vertex is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Vertex Pharmaceuticals
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Vertex Pharmaceuticals. In addition to that, Viracta Therapeutics is 4.18 times more volatile than Vertex Pharmaceuticals. It trades about -0.05 of its total potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest 31,209 in Vertex Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of 14,488 from holding Vertex Pharmaceuticals or generate 46.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viracta Therapeutics vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Viracta Therapeutics |
| Vertex Pharmaceuticals |
Viracta Therapeutics and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and Vertex Pharmaceuticals
The main advantage of trading using opposite Viracta Therapeutics and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Viracta Therapeutics vs. Candel Therapeutics | Viracta Therapeutics vs. Cingulate Warrants | Viracta Therapeutics vs. Unicycive Therapeutics | Viracta Therapeutics vs. Cardio Diagnostics Holdings |
| Vertex Pharmaceuticals vs. Candel Therapeutics | Vertex Pharmaceuticals vs. Cingulate Warrants | Vertex Pharmaceuticals vs. Unicycive Therapeutics | Vertex Pharmaceuticals vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |